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The work carried out during my research tenure has been compiled in the form of a 
thesis entitled “Synthesis and Bioevaluation of N, O Containing Heterocycles and New 
Methodologies”. The main aim of this work is to design and synthesize imidazopyrazine 
derivatives, oxadiazoles, isoxazoles, and developing some new methodologies using 
(Bromodimethyl)sulfonium bromide as a catalyst. The thesis has been divided into three 
chapters.  
 
 Chapter I : Synthesis and Activity Evaluation Studies of Imidazo[1,2-a] 
Pyarazine Derivatives 
 
 Chapter II :  Synthesis and Biological Evaluation of Azole Heterocycles.  
   This chapter is further divided into two sections. 
   Section A: Synthesis of Novel 3,5-Disubstituted-4,5-Dihydro 
Isoxazoles and 3,4,5-Trisubstituted Isoxazoles and Their Biological 
Activity. 
   Section B: Synthesis of Novel 2,5 Disubstituted 1,3,4-Oxadiazoles  
 
 Chapter III : (Bromodimethyl)sulfonium bromide Mediated Organic   
Transformations.  
   This chapter is further divided into four sections. 
   Section A: Thia Michael Addition 
   Section B: Protection of Amines 
   Section C: Three Component One Pot Synthesis of β-Amino Ketones 
   Section D: Thiolysis of Epoxides: (An Easy Access to β-Hydroxy 
Sulfides and Benzoxathiepinones in Solvent Free Conditions) 
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CHAPTER-I 
SYNTHESIS AND ACTIVITY EVALUATION STUDIES OF 
IMIDAZO[1,2-a] PYRAZINE DERIVATIVES 
 
Imidazo[1,2-a]pyrazine is a fused ring system of six and five membered rings with 
nitrogen bridgehead. Imidazo[1,2-a]pyarazines are well known biologically active molecules 
which have shown antibacterial, anti-inflammatory, antiulcer, cardiac stimulating, 
antidepressant, antiproliferative on human lymphocytes, smooth muscle relaxant properties 
and phosphodiesterase inhibitory activities (I). Some of the examples are listed below.  
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The chapter describes synthesis of novel imidazo[1,2-a]pyrazines by varying 
substitution on C2, C3 and C6 carbons adopting suitable methods. The synthesized 
compounds were evaluated for their biological activity i.e. antimicrobial and anticancer.  
 
Synthesis of 2-substituted imidazo[1,2-a]pyrazine:  
2-Substituted imidazo[1,2-a]pyrazines are synthesized by reacting 2-amino pyrazine 
with phenacyl bromide in the presence of a base, anhy. NaHCO3 under reflux conditions 
using ethanol as solvent (6a-k, Scheme 1) in 30-67% yield. 
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N
N N
R2
R1N
N
NH2
R1
R2
Br
O
4a: R1= CH34b: R1= H
a:  R1 = CH3, R2 = Ph
b:  R1 = CH3, R2 = 4-C6H4CH3
c:  R1 = CH3, R2 = 4-C6H4F
d:  R1 = CH3, R2 = t-butyl
e:  R1 = CH3, R2 = coumarinyl
f:   R1 = CH3, R2 = 1-((2-nitrophenoxy)methyl)
                             phenyl
6 (a-k)5
+
NaHCO3, EtOH
reflux
g: R1 = H, R2 = Ph
h: R1 = H, R2 = 4-C6H4F
i:  R1 = H, R2 = 4-C6H4CH3j:  R1 = H, R2 = t-butyl
k: R1 = H, R2 = 4-C6H4Cl
 
Scheme 1 
After successful synthesis of 2-substituted imidazopyrazines, it was further planned 
for electrophilic (bromination, hydroxymethylation, aminomethylation) and nucleophilic 
substitutions (cyanation) on imidazole ring at C3 position by adopting relevant procedures. 
Schematic representations are given below. 
 
(a) Bromination: Bromination has been carried out on 2-substituted imidazo[1,2-a] pyrazine 
using NBS in ethanol  at room temperature to obtain corresponding 3-bromo-2-substituted 
imidazo[1,2-a]pyarzines (7a-k, Scheme 2) in 54-87% yield. 
N
N N
R1
R2
6 (a-k)
N
N N
R1
R2
Br
7 (a-k)
NBS, EtOH
rt
a:  R1= CH3, R2 = C6H5
b:  R1= CH3, R2 = 4-C6H4CH3
c:  R1= CH3, R2 = 4-C6H4F
d:  R1= CH3, R2 = t-butyl
e:  R1= CH3, R2 = coumarinyl
f:   R1= CH3, R2 = 1-((2-nitrophenoxy)methyl)
                             phenyl
g:  R1= H, R2 = C6H5
h:  R1= H, R2 = 4-C6H4F
i:   R1= H, R2 = 4-C6H4CH3j:   R1=H, R2 = t-butyl
k: R1= H, R2 = 4-C6H4Cl
 
Scheme 2 
(b) Hydroxymethylation: Hydroxymethylation has been carried out on 2-substituted 
imidazo[1,2-a]pyrazine in the presence of formaldehyde, acetic acid, sodium acetate at  
60 °C for 24 h to afford 3-hydroxymethyl-2-substituted imidazo[1,2-a]pyrazine (9a-b, 
Scheme 3) in 40-45% yield. 
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N
N N
H3C
R N
N N
H3C
R
OH
e: R = 3-coumarinyl 
k: R= 1-((2-nitrophenoxy)methyl)phenyl
HCHO, AcOH, Ac2O
60 °C
6e, 6k 9a, 9b
a: R = 3-coumarinyl 
b: R= 1-((2-nitrophenoxy)methyl)phenyl
 
Scheme 3 
 
(c) Aminomethylation: Aminomethylation has been carried by reacting secondary amine 
(morpholine, piperidine, pyrrolidine), formaldehyde with imidazo[1,2-a]pyrazine in 
methanol and acetic acid under reflux conditions to 3-aminomethyl-2-substituted 
imidazo[1,2-a]pyrazine (10a-j, Scheme 4) in 45-72% yield. 
 
N
N N
R1
R2
sec.amine, HCHO, AcOH
N
N N
R1
R2
R3
10a: R3 = Piperidinyl, R2 = C6H5, R1= CH3
10b: R3 = Morpholinyl, R2 = C6H5, R1= CH3
10c: R3 = Piperidinyl, R2 = 4-C6H4F, R1= CH3
10d: R3 = Morpholinyl, R2 = 4-C6H4F, R1 = CH3
10e: R3 = Morpholinyl, R2 = 4-C6H4CH3, R1= CH3
CH3OH, reflux
10(a-j)6(a-d, h, k)
10f:  R3 = Morpholinyl, R2 = t-Bu, R1 = CH3
10g: R3 = Piperidinyl, R2 = 4-C6H4F, R1 = H
10h: R3 = Pyrrolidinyl, R2 = 4-C6H4F, R1 = H
10i:  R3 = Morpholinyl, R2 = 4-C6H4F, R1 = H
10j:  R3 = Piperidinyl, R2 = 4-C6H4Cl, R1 = H
 
Scheme 4 
 
(d) Nucleophilic substitution on 3-bromo-2-substituted imidazo[1,2-a]pyrazine:  
3-Bromo-2-substituted imidazo[1,2-a]pyrazine was reacted with CuCN in DMF under reflux 
conditions to obtain corresponding 3-cyano-2-substituted imidazo[1,2-a]pyrazine (8a-f, 
scheme 5) in 40-54% yield. 
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N
N N
R1
R2
Br
N
N N
R1
R2
CN
7 (a-c, f, h, k)
CuCN, DMF
8a: R2 = Ph, R1= CH3
8b: R2 =4-C6H4CH3, R1=  CH3
8c: R2 =4-C6H4F, R1= CH3
8 (a-f)
reflux
8d: R2 =1-((2- nitrophenoxy)
              methyl)phenyl, R1= CH3
8e: R2 =4-C6H4Cl, R1= H
8f:  R2 =4-C6H4F, R1= H
 
Scheme 5 
All the compounds were characterized by chemical and spectral means. 
 
Biological Activity: 
All the synthesized compounds are screened for their antibacterial, antifungal activity. 
Among the listed compounds 7a, 7i, 10b have shown moderate antibacterial activity and 7a, 
7f, 7b have shown good antifungal activity compared to standards. 
The compounds were also screened for anticancer activity against four cell lines.  
Compound 7a exhibited the most cytotoxic effects on all the four cell lines with best against 
MCF-7 and SK-N-SH at 13.0 and 13.8 µM respectively. The next best molecule in this series 
is 8c with activities close to 100 µM. When fluoro is replaced by chloro substitution the 
efficiency of cytotoxicity improves by about eight folds in two cell lines while it remains the 
same in other two cell lines. Out of the five new C3-cyano derivatives, only 8c displayed 
appreciable efficiency against HEPG-2 cell lines. 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                        Synopsis 
 
 
vi 
 
CHAPTER-II 
SYNTHESIS AND BIOLOGICAL EVALUATION OF AZOLE HETEROCYCLES 
 
Azoles are a class of heterocycles containing at least one nitrogen in their structure. 
Azoles are core molecules encompassing pharmacological / agrochemical activity which 
prompted towards synthesis of novel heterocycles containing azole moiety like isoxazoles, 
dihydroisoxazoles and oxadiazoles. The chapter deals with hitherto unreported new 
molecular frameworks encompassing isoxazoles, dihydroisoxazoles and oxadiazoles into 
halo substituted pyridinyloxy phenyl moiety using chloramine-T as a catalyst. The chapter is 
further divided into two sections. 
 
Section A: Synthesis of Novel 3,5-Disubstituted-4,5-Dihydroisoxazoles and 3,4,5-
Trisubstituted Isoxazoles and Their Biological Activity 
Isoxazole derivatives have shown COX-2 inhibitory, antiviral, anticonvulsant, 
analgesic, antinociceptive and anticancer activities (II). This section describes synthesis of 
3,5-disubstituted-4,5-dihydroisoxaoles and  3,4,5-trisubstituted isoxazoles and their 
biological activity. 
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II 
 
3, 5–Disubstituted-4,5-dihydroisoxaole: 
The starting materials used for the synthesis of isoxazoles include diketones, α,β-
unsaturated compounds and  aldehydes etc. Aldehyde oximes were found to be the most 
suitable simple substrates. Thus, few hitherto unreported halopyridinyloxybenzaldehydes 
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have been chosen as starting materials from which oximes were generated. The oximes were 
then condensed with styrene in the presence of chloramine-T as shown in the scheme-6.  
 
N
Cl
Cl
Cl
N
Cl
Cl
Cl
ClN
ClCl
R  =
N
O
RO
6a-f
HO
CHO
1a-c
2a-bR−Cl
RO
CHO
3a-f
RO
4a-f
N OH Method A
Method B
RO
N OH
Cl
or or
5a-f
a
b
c
d
e
 
Reagents and conditions: a) anhy. K2CO3, dry. DMF, 70 °C; b) NH2OH·HCl, pyridine, EtOH, reflux; c) 
chloramine-T, styrene, EtOH, reflux; d) NCS, DMF, rt; e) TEA, DCM, styrene, rt. 
 
Scheme 6 
 
Halo substituted pyridine(s) was reacted with p/m-hydroxybenzaldehyde in the 
presence of anhy. K2CO3 in dry DMF at 70 °C to obtain pyridinyloxybenzaldehydes which 
on further treatment with hydroxylamine hydrochloride in the presence of pyridine yielded 
corresponding oxime(s). The oxime(s) was reacted with styrene and chloramine-T in ethanol 
(method A) under reflux conditions to isoxazolines.  
After successful synthesis of mono dihydro isoxazoles, bisaldehydes were taken up as 
starting materials for synthesis of bis isoxazolines. Bis aldehydes were converted into bis 
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oximes, followed by treatment with NCS. The C-chlorooxime(s) are further condensed with 
styrene using TEA base (method B) to obtain the product (Scheme 7, 9a-b).  
 
N OO
ClCl
OHC CHO
7a-b
O N
8a-b
9a-b
N OO
ClCl
NOHHON
N OO
ClCl
ON
a
b
 
Reagents and conditions: a) NH2OH·HCl, EtOH, reflux; b) i) NCS, DMF, rt; ii) TEA, styrene, DCM, rt. 
Scheme 7 
 
All the synthesized compounds were tested for antibacterial and antifungal activity 
and action on the isolated frog heart muscle. 
4,5-Dihydroisoxazole derivatives, 6d and 6e showed inhibitory activity on 
Staphylococcus aureus. Compounds 6a and 6b showed inhibitory activity on Salmonella 
typhimurium. Aldoxime derivatives, 2e and 2f showed inhibitory activity on Staphylococcus 
aureus. On the whole inhibitory activity of aldoxime derivatives was found to be better than 
4,5-dihydroisoxazole derivatives. The 4,5-dihydroisoxazole derivatives did not show any 
activity on fungal strains, while oxime derivatives, 5e and 5f showed better inhibitory 
activity on Candida albicans. 
Phenoxy pyridines were reported to possess reverse mode sodium calcium exchanger 
inhibitory activity. Hence in the present study, compounds are tested on isolated frog heart on 
a qualitative basis. The compounds, 6a-6f reduced the heart rate, cardiac output and force of 
contraction but not as significant as diltiazem. Compound(s) 9a and 9b showed better 
inhibition when compared to other compounds.  
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Synthesis of 3,4,5-Trisubstituted isoxazole: 
From literature it was observed that nitrile oxide addition to the α,β-unsaturated 
ketones  leads to 3,4,5-trisubstituted isoxazoline formation, but in our case when  
C-chloroxime is condensed with α,β-unsaturated ketones, surprisingly 3,4,5-tri substituted 
isoxazoles were obtained (Scheme 8). This could be due to traces of NCS remaining in the 
reaction mixture which further oxidizes isoxazolines to isoxazoles. This explanation was 
substantiated by the literature data. 
 
NOH
NCS, DMF
rt, 1 h
R1
Et3N, DCM, rt
O
R2
N O
O
R1
R3
R2
10
12
R1 = NO2, Cl, OH, 2, 6-dichloro
R2 = Cl, F,CH3, H
R3 = CH3 , 2, 6-dichloro, NO2, OCH3, Cl
13a: R1 = 4-NO2;
13b: R1 = 4-Cl;
13c: R1 = 4-Cl;
13d: R1 = 4-Cl;
13e: R1 = 4-Cl;
13f:  R1 = 4-OH;
13g: R1 = 4-F;
NOH
R1
11
Cl
R312
13a-g
R3 = 4-CH3
R3 = 2,6-dichloro
R3 = 4-NO2
R3 = 4-OCH3
R3 = 4-OCH3
R3 = 4-Cl
R3 = 4-Cl
R2 = 4-Cl;
R2 = 4-NO2;  
R2 = 4-CH3;  
R2 = 4-Cl;     
R2 = 4-F;      
R2 = 4-CH3; 
R2 = 4-H;
 
CHO NOHCl
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Scheme 8 
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The synthesized compounds have been tested for antibacterial activity.  3,4,5-Tri 
substituted isoxazoles showed moderate  antibacterial activity, while three compounds 13a, 
13b, 13c showed some antifungal activity of lower order. The compound 13c, showed good 
activity against both bacterial (Salmonela typhimurium) and fungal (Candida albicans) 
strains. 
 
Section B: Synthesis of Novel 2,5-Disubstituted-1,3,4-Oxadiazoles from Pyridyl Ethers 
Literature reveals that 1,3,4-oxadiazoles have shown a wide range of pharma and 
biological activities as well as polymer and material science applications. They have been 
found to possess antiviral, antibacterial antimalarial, antifungal, anticonvulsant, anti-
inflammatory and analgesic properties (III). 
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III
 
This activity profile inspired us to synthesize new molecular frame work of 2,5-di 
substituted-1,3,4-oxadiazoles incorporating pyridinyloxy phenyl system.  
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Reagents and conditions: a) EtOH, reflux; b) Chloramine-T, EtOH, reflux 
Scheme 9 
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Following the success of oxadiazole derivatives synthesis further bis oxadiazoles 
have been attempted   following the same method. 
 
N OO
ClCl
OHC
a
7a-b 17a-b
CHO N OO
ClCl
NN
H
Ph
O
N N
H
Ph
O
b
18a-b
N OO
ClCl
NN
O
Ph
N N
O
Ph
  
Reagents and conditions: a) PhCONHNH2, EtOH, reflux; b) Chloramine-T, EtOH, reflux. 
Scheme 10 
Biological Activity: 
All the compouns were tested for antibacterial activity against S. aureus and E.coli. In 
antibacterial activity screening, excepting one compound 16f all the other compounds 
showed activity against the Gram (-ve) bacterium E. coli. The 2,5-disubstituted-1,3,4-
oxadiazoles, 16a had  better inhibition against E. coli compared to streptomycin. 
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CHAPTER-III 
(BROMODIMETHYL)SULFONIUM BROMIDE MEDIATED 
 ORGANIC TRANSFORMATIONS 
 
The solvent free methods constitute an excellent tool for accomplishing 
environmentally friendly organic reactions. Solvent free reactions are generally rapid, highly 
selective and often gave high yields. Our  interest in the development of new protocols for  
the synthesis of bioactive molecules and intermediates under solvent free conditions led to 
the application of (bromodimethyl)sulfonium bromide catalyst,  a mild, versatile, and 
effective acid catalyst for many organic transformations. This chapter is further divided into 
four sections. 
 
Section A: Thia Michael addition 
The section demonstrates BDMS catalyzed Michael addition of mercaptans to α,β-
unsaturated carbonyl compounds to β-mercaptocarbonyl compounds, the useful intermediates 
for synthesis of bio active molecules. 
R
O
R1 R2
+
R
O
R1 SR3R2
Neat
R3SH
Me2S+Br Br-
1 2 3
3a:  R1= 4-ClC6H4 : R2= C6H5 : R3=C6H5
3b:  R1= 4-ClC6H4 : R2= C6H5 : R3=C2H5
3c:  R1= 4-NO2C6H4 : R2= 2,6-dichloroC6H3 : R3=C6H5
3d:  R1= 4-NO2C6H4 : R2= 2,6-dichloroC6H3 : R3=C2H5
3e:  R1= 1,2 dimethyl propane : R2=  4-NO2C6H4 : R3=C6H5
3f:   R1= 1,2 dimethyl propane : R2=  4-NO2C6H4 : R3=C2H5
3g:  R1= 4-ClC6H4 : R2= 4-FC6H5 : R3=C6H5
3h:  R1= 4-ClC6H4 : R2= 4-FC6H5 : R3=C2H5
3i:   methylvinyl ketone :
 
R3=C6H5  
3j:   methylvinyl ketone :
 
R3=C2H5  
3k:  R1=4-OCH3 : R2=C6H4 : R3=C6H5 : R3=C6H5
3l:   R1= 2-ClC6H4 : R2= 4-CH3C6H5 : R3=C6H5
3m: cyclohexenone : R3=C6H5
3n:  cyclohexenone : R3=C2H5
 
Scheme 11 
The reaction proceeds spontaneously with 5 mol% of catalyst with aromatic as well 
as aliphatic thiols (Scheme 11). It was also found that the addition of thiophenol was faster 
and gave better yields compared to ethane thiol. The reaction proceeds efficiently even with 
solid α,β-unsaturated ketones. 
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Section B: Protection of Amines 
The protection of amino group is a key step in peptide and synthetic organic 
chemistry. The protection was achieved by various acid and base catalysts. Most commonly 
used reagents to protect amines are t-(Boc)2O and Cbz chloride. This section provides BDMS 
catalyzed simple, mild, efficient protocol for the protection of amines (both aryl and aliphatic 
amines) using (Boc)2O and Cbz chloride at ambient temperature under solvent free 
conditions (Scheme 12). 
RNH2
Me2SBr2 Ph O
O
N
H
R
R  = H, Alkyl
R1 = Alkyl, Aryl
(4-15)
CbzCl (Boc)2O
NHBoc
R
(16-24)
Me2SBr2
R = H, Alkyl
R1 = Alkyl, Aryl
RNH2
16:   R = benzylamine            
17:   R = C6H5    
18:   R = 1-phenylethanamine 
19:   R = 4-Methylpiperidine 
20:   R = 2-aminoethanol 
21:   R = benzo[d]thiazol-2-amine 
22:   R = methyl 2-amino-3-phenylpropanoate
23:   R = morpholine
24:   R = (S)-1-amino-1-((3aR,6S,6aR)-6-methoxy-2,2- 
               dimethyl-tetrahydrofuro[3,2-d][1,3]dioxol-3-one
 4a:   R = 2-methoxybenzylamine            
 4b:   R = benzylamine     
 4c:   R = 4-triflouro methylbenzylamine      
 5:     R = 2-phenylethanamine
 6:     R = C6H5
 7:     R = 1-phenylethanamine
 8:     R = morpholine
 9:     R = 1- Methyl piperzine
10a:  R = 2-aminoethanol
10b:  R = 2-methoxyethanamine
11:    R = 2-amino pyridine
12:    R = benzo[d]thiazol-2-amine
13:    R = methyl 2-amino-3-phenylpropanoate
14:    R = methyl 7-chloro-2,3,4a,5-tetrahydroindeno
                [1,2-e][1,3,4]oxadiazine-4a-carboxylate
15:    R = (S)-1-amino-1-((3aR,6S,6aR)-6-methoxy-2,2-di 
                methyl-tetrahydrofuro[3,2-d][1,3]dioxol-3-one
 
Scheme 12 
 
Protection is efficient with primary and also with secondary amines by both (Boc)2O 
and Cbz chloride. The reaction rate is faster and gave better yields with primary amines 
compared to secondary amines. The interesting feature of this protocol is facile protection of 
the amino group of α-amino acid ester as well as β-amino acid esters. Additionally, the 
method is highly chemo selective because only amine is protected even in the presence of 
bifunctional compounds possessing alcohol. 
  
Section C: Three Component One Pot Synthesis of β-Amino Ketones  
β-Amino carbonyl compounds are  useful intermediates for the synthesis of 
biologically important natural products, antibiotics, β-amino alcohols and other nitrogen 
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containing compounds. This has led to the development of novel synthetic methodology for 
β-amino carbonyl compounds. 
CHO NH2
Me2SBr2
O NH
R1
rt
+ +
R2
R2
R1
O CH3
25-39
25: R1 = H : R2 = H
26: R1 = 4-ClC6H4 : R2 = H
27: R1 = 4 -CH3C6H4 : R2 = H
28: R1 = 3,6-dimethoxy C6H3 : R2 = H
29: R1 = 2,6-dichloro C6H3 : R2 = H
30: R1 = 4 -NO2C6H4 : R2 = H
31: R1 = H : R2 = 4-Cl C6H4
32: R1 = H : R2 = 4-F C6H4
33: R1 = H : R2 = 2-Cl, 4-F C6H3
34: R1 = H : R2 = 4-Br C6H4
35: R1 = H : R2 = 4-CF3 C6H4
36: R1 = H : R2 = 2-F, 4-F C6H3
37: R1 = H : R2 = 4-CH3 C6H4
38: R1 = H : R2 = 4-OCH3 C6H4
39: R1 = H : R2 = 4-NO2 C6H4
 
Scheme 13 
 
The section describes, BDMS mediated one pot solvent free condensation of 
aldehydes, enolisable ketones with amines to generate β-amino carbonyl compounds 
(Scheme 13). Reaction proceeds in solvent free conditions with the solid anilines also. In 
case of solid aldehydes, ethanol was used as solvent for the reaction. To know the efficacy of 
the catalyst, the reaction was carried out using ZrCl4 and I2. The results in both the cases not 
satisfactory even in presence of solvent medium.  
 
Section D: Thiolysis of Epoxides: (An Easy Access to β-Hydroxy Sulfides and 
Benzoxathiepinones in Solvent Free Conditions) 
Thiolysis of oxiranes by sulfur gives β-hydroxysulfides which are important 
intermediates for pharmaceutical and natural products. The present work deals with opening 
of epoxide by aliphatic and aromatic thiols in the presence of 10 mol% of BDMS at room 
temperature under solvent free conditions in 75-98% yield (Scheme 14). It was observed that 
when aromatic epoxide was opened by the thiol, the regio chemistry of opening was at 
benzylic position and gave primary alcohol. Where as with aliphatic epoxides it was opposite 
and gave secondary alcohol. The products were confirmed by their spectral data. 
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O
R1
OHS
R1
R2
Me2SBr2
R2 SH
rt
R1
OH
SR2
R2 = Ph, substituted phenyl, alkyl,
      thioalkyl etc.
R1 = Ph, substituted phenyl
R1 = CH2Cl, alkyl etc.
 
Scheme 14 
 
This protocol is satisfactory even with bifunctional thiols like p-aminothiophenol, p-
bromothiophenol. The catalyst has been found to be very efficient even with  disulphide as 
nucleophile for epoxide opening wit half the stochiometry of disulphide to oxirane, 10 mol% 
catalyst was effective in converting the reaction in ethanol medium and yields of 85-92% 
were obtained (Scheme 15). 
R
O S
S
R
HO
S
Ethanol, rt
Me2SBr2
61: R =   C6H5
62: R = CH2Cl
63: R = CH3
64: R =4-CH3C6H5
61-64
 
Scheme 15 
Interesting results were obtained when styrene epoxide is treated with thiosalicylic 
acid. Benzoxathiepinones a cyclized product was obtained in 93% yield at ambient 
temperature, as confirmed by the spectral data, where as when thiosalicylic acid was reacted 
with epichlorohydrin, only open chain product was obtained in 88% yield (Scheme 16). 
R
O
SH
O
OH
S
O
O
Rrt
Me2SBr2
65: R = C6H5
66: R = 4-CH3C6H5
65-66
 
Scheme 16 
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Conclusion: 
We have successfully synthesized N, O containing heterocycles like imidazo 
pyrazines, isoxazoles, isoxazolines and oxadiazoles and evaluated their bioactivity. 
Imidazo[1,2-a]pyrazines derivatives have shown good anticancer and moderate antimicrobial 
activity. 3,5-Disubstituted-4,5-dihydroisoxazoles and oxadiazoles containing halo 
pyridinyloxy phenyl as core moiety were also exhibiting antibacterial  activity. Some of the 
isoxazoline compounds have shown action on isolated frog heart. 3,4,5-Trisubstituted 
isoxazoles exhibit moderate activity. We have shown (bromodimethyl)sulfonium bromide  
mediated organic transformations under solvent free,  green conditions. 
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